Results 71 to 80 of about 59,400 (291)

Differentiating Non-Motor Symptoms in Parkinson's Disease from Controls and Hemifacial Spasm [PDF]

, 2013
10.1371/journal.pone.0049596PLoS ...
A Schrag, AA Kehagia, AJ Hughes, CL Tomlinson, D Aarsland, DD Truong, DW Dickson, E Tolosa, E Wolters, EH Kua, EK Tan, Eng-King Tan, G Defazio, H Braak, H Li, HJ Kim, John C. Allen, KR Chaudhuri, KR Chaudhuri, KR Chaudhuri, Kumar M. Prakash, MA Hely, Mathias Toft, Ming-Hui Yong, MM Hoehn, N Pavese, NC Tan, NJ Diederich, P Barone, P Martinez-Martin, P Martinez-Martin, S Jain, S Krishnan, SY Lim, T Ziemssen, Z Qin   +35 more
core   +2 more sources

Hemifacial Spasm Caused by Vascular Compression in the Cisternal Portion of the Facial Nerve: Report of Two Cases with Review of the Literature

Case Reports in Neurological Medicine, 2019
Although primary hemifacial spasm (HFS) is mostly related to a vascular compression of the facial nerve at its root exit zone (REZ), its occurrence in association with distal, cisternal portion has been repeatedly reported during the last two decades. We
B. Son, Hak-Cheol Ko, Jin-Gyu Choi
semanticscholar   +1 more source

Dry Needling Can Be An Alternative Treatment for Hemifacial Spasm [PDF]

, 2020
Back Ground: Hemifacial spasm is one of movement disorder case that commonly found in daily clinical practice. Epidemiological data are very limited, the average prevalence is 11 per 100,000 population, 14.5 per 100,000 in women and 7.4 per 100,000 in ...
Marisdina, Selly, Pradian, A, Sugiharto, Henry   +2 more
core   +2 more sources

Secondary or Symptomatic Hemifacial Spasm caused by a Tumor of Cerebellopontine Angle Case Report and Review of the Literature

Iranian Journal of Neurosurgery, 2015
Background & Importance: Primary hemifacial spasm is usually caused by microvascular compression of the facial nerve at its root exit zone at brainstem without any space-occupying pathology.
Mohammad-Javad Mirzayan, Morteza Faghih Jouibari, Ahmad Aoude, Seyed-Mohammad Ghodsi   +3 more
doaj  

Dissecting the Phenotypic Spectrum and Complexity of Movement Disorders in 22q11.2 Deletion Syndrome

European Journal of Neurology, Volume 32, Issue 6, June 2025.
In this study, we deeply phenotyped 31 unrelated adults with molecular confirmation of 22q11.2 microdeletion who were referred for neurologic assessments at a major centre of excellence in movement disorders. At the group level, majority (77%) presented with two or more movement disorder phenotypes, with similar trends in prevalence after accounting ...
Nikolai Gil D. Reyes, Talyta Grippe, Marcus Callister, Tarig Abkur, Emilio Q. Villanueva III, Tracy Heung, Robert Chen, Erik Boot, Anne S. Bassett, Anthony E. Lang   +9 more
wiley   +1 more source

Health-related quality of life outcomes from botulinum toxin treatment in hemifacial spasm

Therapeutic Advances in Neurological Disorders, 2017
Background: Although botulinum neurotoxin (BoNT) injections may alleviate involuntary muscle contractions in hemifacial spasm substantially, it is less clear whether the motor effect would translate into improvements of health-related quality of life (HR-
Daniel Weiss, Justine Sturm, Leonhard Hieber, Axel Börtlein, Ingo Mayr, Matthias Appy, Benedicta Kühnler, Joachim Buchthal, Christian Dippon, Guy Arnold, Tobias Wächter   +10 more
doaj   +1 more source

Endoscope-assisted retrosigmoid approach in hemifacial spasm: our experience [PDF]

, 2018
Introduction: The use of surgical decompression of facial hemispasm due to the loop in the internal auditory canal is not always accepted due to the risk related to the surgical procedure.
Antonio della Volpe, Arianna Di Stadio, Franco Trabalzini, Giampietro Ricci, Jacques Magnan, Luca D'Ascanio, Ruggero La Penna   +6 more
core   +2 more sources

Fully endoscopic microvascular decompression for hemifacial spasm.

Journal of Neurosurgery, 2019
OBJECTIVEHemifacial spasm (HFS) is characterized by involuntary tonic and/or clonic contractions of facial nerve muscles. Fully endoscopic microvascular decompression (E-MVD) for HFS has not been widely adopted.
Tracy M. Flanders, Rachel Blue, Sanford E. Roberts, B. Mcshane, Bryan Wilent, Vijay Tambi, D. Petrov, John Y. K. Lee   +7 more
semanticscholar   +1 more source

Effect on Pain Following One Session of Botulinum Toxin Type A in Patients With Jaw Myalgia: A Randomised Double‐Blind Controlled Multicentre Pilot Study

Journal of Oral Rehabilitation, Volume 52, Issue 5, Page 587-596, May 2025.
ABSTRACT Background Botulinum toxin Type A (BTX‐A) is increasingly used in the management of myofascial pain; however, the evidence to support this treatment modality is still inconclusive. Objective To evaluate the change in days with functional jaw pain after one session of BTX‐A or placebo injections into the masseter and temporalis muscles in ...
Ava Minston, Helene Abrahamsson, Peter Abrahamsson, Erik Lindfors, Eva Nohlert, Daniel Ovesson, Negin Yekkalam, Göran Isacsson   +7 more
wiley   +1 more source

Botulinum toxin type A efficient treatment in patients with hemifacial spasm, Guantanamo 2018-2019

Revista Información Científica, 2020
Introduction: no research records were found addressing the results of the application of botulinum toxin type A in patients with hemifacial spasm in Guantanamo province.
Talía Marzo-Ramírez, Tamara Mecías-Díaz   +1 more
doaj